Lars Lindén
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Protein purification and stability 7
- Photosynthetic Processes and Mechanisms 3
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Rainer Fischer (2 shared papers)Dmitrij Hristodorov (2 shared papers)Beate Müller‐Tiemann (4 shared papers)Jörg Freigang (1 shared paper)Robert Huber (1 shared paper)Karl Ziegelbauer (4 shared papers)Günter Auerbach (1 shared paper)Stefan Steinbacher (1 shared paper)
- Journals
- Journal of the Association for Information Systems (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- GermanyUnited StatesTaiwan
In The Last Decade
Lars Lindén
27 papers receiving 635 citations
Peers
Comparison fields: 5 of 100
- Radiology, Nuclear Medicine and Imaging 279
- Oncology 192
- Biotechnology 56
- Pulmonary and Respiratory Medicine 146
- Molecular Biology 267
Countries citing papers authored by Lars Lindén
This map shows the geographic impact of Lars Lindén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Lindén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Lindén more than expected).
Fields of papers citing papers by Lars Lindén
This network shows the impact of papers produced by Lars Lindén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Lindén. The network helps show where Lars Lindén may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Lindén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 191 | |
| 2 | 2004 | 87 | |
| 3 | 2012 | 58 | |
| 4 | 2012 | 54 | |
| 5 | 2019 | 40 | |
| 6 | 2019 | 29 | |
| 7 | 2012 | 27 | |
| 8 | 1976 | 26 | |
| 9 | 1995 | 23 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2014 | 13 | |
| 13 | 2012 | 12 | |
| 14 | 1995 | 11 | |
| 15 | 2014 | 8 | |
| 16 | 2017 | 7 | |
| 17 | 2007 | 7 | |
| 18 | 2011 | 5 | |
| 19 | 2018 | 4 | |
| 20 | 2017 | 4 |
About Lars Lindén
Lars Lindén is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 27 papers that have together received 652 indexed citations. Recurring topics across this work include Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Open Source Software Innovations (3 papers), Transgenic Plants and Applications (3 papers), Photosynthetic Processes and Mechanisms (3 papers), Big Data and Business Intelligence (2 papers), HER2/EGFR in Cancer Research (2 papers) and Software Engineering Techniques and Practices (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (279 citations), Oncology (192 citations), Biotechnology (56 citations), Pulmonary and Respiratory Medicine (146 citations) and Molecular Biology (267 citations). Lars Lindén has collaborated with scholars based in Germany, United States and Taiwan. Frequent co-authors include Rainer Fischer, Dmitrij Hristodorov, Beate Müller‐Tiemann, Jörg Freigang, Robert Huber, Karl Ziegelbauer, Günter Auerbach, Stefan Steinbacher, Georg Kreimer and Bertolt Kreft. Their work appears in journals such as Journal of the Association for Information Systems, Cancer Research, Molecular Cancer Therapeutics, Molecular Pharmaceutics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.